文献速递造血干细胞移植与细胞治疗白血病

粒细胞输注后脐血CD8+ T细胞扩增清除难治性白血病

Cord blood CD8+ T-cell expansion following granulocyte transfusions eradicates refractory leukemia.
PubMed 文献 · Blood Adv · 2020-01-01

本文报告4例高危儿童白血病患者在接受T细胞充足脐血移植后、输注第三方混合粒细胞,出现早期短暂而强烈的CD8+ T细胞扩增,细胞呈多克隆、快速记忆表型并具细胞毒能力,无GVHD且长期缓解。提示胎儿来源脐血CD8+ T细胞可产生强抗白血病效应而不引发GVHD。

要点

  • T细胞充足脐血移植后输注第三方混合粒细胞可触发早期CD8+ T细胞扩增。
  • 扩增的脐血CD8+ T细胞为多克隆、快速记忆表型并具细胞毒能力。
  • 4例高危儿童白血病患者均长期缓解且无GVHD。

核心结论

  • 胎儿来源脐血CD8+ T细胞可被利用产生强抗白血病效应而不引发GVHD。

研究设计与样本

  • 观察性报告:4例高危儿童白血病患者接受T细胞充足脐血移植后输注第三方混合粒细胞。

主要发现

  • 4例患者出现早期短暂而强烈的T细胞扩增,包括CD8+ T细胞扩增,不同于T细胞充足脐血移植后通常观察到的CD8+ T细胞延迟扩增。
  • 扩增的CD8+ T细胞为多克隆、快速转换为记忆表型并具有介导细胞毒性的能力。
  • 该现象可重复,每例患者均保持长期缓解且无GVHD。

临床怎么用

  • 提示T细胞充足脐血移植后输注第三方混合粒细胞可能触发早期脐血CD8+ T细胞扩增并增强抗白血病效应。
  • 该现象与无GVHD的长期缓解相关,支持进一步探索脐血CD8+ T细胞抗白血病治疗策略。

局限性

  • 仅为4例患者的观察性报告,证据等级有限。
  • 原文未报告对照设计或机制验证实验。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The action of hematopoietic cell transplantation in controlling leukemia is principally mediated by donor T cells directed against residual recipient malignant cells. However, its utility is limited by graft-versus-host disease (GVHD), where alloreactivity is extended beyond leukemic and marrow cells. In a human/murine chimeric model, we previously showed that the preferential infiltration of cord blood (CB) CD8+ T cells eradicates an Epstein-Barr virus-driven lymphoblastoid tumor without causing xenogeneic GVHD. In the clinic, however, cord blood CD8+ T-cell reconstitution is significantly delayed, and the observation of such a robust antileukemia effect mediated by cord blood CD8+ T cells has not been reported. We describe an observation of very early T-cell expansion in 4 high-risk pediatric leukemia patients receiving third-party, pooled granulocytes after T cell-replete CB transplantation (CBT). The T-cell expansion was transient but robust, including expansion of CD8+ T cells, in contrast to the delayed CD8+ T-cell expansion ordinarily observed after T cell-replete CBT. The CD8+ T cells were polyclonal, rapidly switched to memory phenotype, and had the ability to mediate cytotoxicity. This phenomenon is reproducible, and each patient remains in long-term remission without GVHD. The results suggest that fetal-derived CB CD8+ T cells can be exploited to generate robust antileukemia effects without GVHD.

来源:Blood Adv,查看原文。版权归原作者所有。

引用

  1. Hiwarkar P, Adams S, Gilmour K, et al. Cord blood CD8+ T-cell expansion following granulocyte transfusions eradicates refractory leukemia. Blood Adv. 2020. PMID: 32886752. doi:10.1182/bloodadvances.2020001737

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。